EUVIMEDEUVIMED entdecken
Crossref

L26/P-728 Oocyte quality and competence in poor ovarian reserve: Insights from AI-based assessment, morphokinetics, ploidy and clinical outcomes

G. Teles, M. Cavagnoli, V. Ambrósio, M.A. Tamm, A. Micucci, D. Braga, E. Borges, M. Del Collado

Human Reproduction · 01.07.2026 · 41 (Supplement_1)

DOI: 10.1093/humrep/deag083.1055 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Human Reproduction, online erschienen am 08.07.2026. Verfasst von G. Teles und 7 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Study question Does poor ovarian reserve (POR) impair oocyte quality or competence assessed using AI-based metrics, morphokinetics, ploidy analysis, and clinical outcomes? Summary answer POR did not impair AI-based oocyte or embryo quality, morphokinetics, euploidy, laboratory outcomes, implantation, or miscarriage rates. What is known already POR is associated with reduced reproductive success, traditionally attributed to impaired oocyte number. However, whether POR intrinsically compromises oocyte quality remains controversial. Recent advances in AI-based tools enable objective assessment of oocyte and embryo quality, while time-lapse morphokinetics and ploidy analysis provide deeper insight into embryo developmental potential. Studies integrating these technologies with clinical outcomes are limited, particularly in distinguishing quantitative restrictions from true qualitative impairments in POR patients. Study design, size, duration This retrospective cohort study included ICSI cycles performed between 2020 and 2024. A total of 314 cycles were analyzed, including 171 control cycles and 143 poor ovarian reserve cycles. After 1:1 propensity score matching (PSM) for female age, 143 cycles per group were included, comprising 1,382 retrieved oocytes. Participants/materials, setting, methods Cycles were classified as control (AMH ≥1.2 ng/mL and/or AFC ≥5) or POR (AMH <1.2 ng/mL and/or AFC <5). Oocyte and embryo quality was assessed using the AI-based scores. Embryonic morphokinetics, laboratory outcomes, ploidy, and clinical outcomes, including cumulative pregnancy, implantation, and miscarriage rates, were evaluated. Oocyte- and embryo-level analyses used generalized linear mixed models, and clinical outcomes were analyzed at the cycle level. Main results and the role of chance Following PSM, female and male age, gonadotropin total dose and COS type did not differ between groups. Oocyte score was comparable between groups (CTR: 5.82±0.1 vs 5.83±0.13). Laboratory performance did not differ between groups, including maturation rate (76.37%±1.84 vs. 75.82%±2.01) fertilization rates (73.13%±2.19 vs. 71.62%±2.42), or blastocyst formation rates (57.28%±2.87 vs. 54.16± 3.42). Embryo ploidy was also not affected, with euploid rates per biopsied blastocyst of 31.095% ± 03.56 vs. 34.73% ± 05.65, and euploid rates per injected oocyte of 18.32%±2.26 vs. 16.17%±3.35, for the CTR and POR groups, respectively. Except for the synchronized cell division parameter S3, where the POR group showed a longer time (8.68±0.74) compared to the CTR group (6.47±0.40), no significant differences were observed in the timings of tPNf, t2, t3, t4, t5, t6, t7, t8, tm, tB, and tSB, nor in synchronized cell divisions S1 or S2, or cell cycles cc2 and cc3. Embryo quality assessed by AI did not differ between groups (CTR: 4.22± 0.12 vs POR: 4.13±0.18). Clinically, implantation and miscarriage rates did not differ between groups. As expected, cumulative pregnancy rate was lower in POR (CTR: 60.9% (64/105) vs POR: 41.2% (35/85)). Limitations, reasons for caution The retrospective design limits causal inference. Despite age matching, residual confounding cannot be fully excluded. Clinical outcome analyses included fewer cycles than laboratory assessments, warranting cautious interpretation. Wider implications of the findings These findings support the concept that poor ovarian reserve primarily limits reproductive success through reduced oocyte quantity rather than compromised biological quality or competence, informing patient counseling and individualized clinical decision-making. Trial registration number No

Zitieren

APA

Teles, G., Cavagnoli, M., Ambrósio, V., Tamm, M., Micucci, A., Braga, D., Borges, E., & Collado, M. D. (2026). L26/P-728 Oocyte quality and competence in poor ovarian reserve: Insights from AI-based assessment, morphokinetics, ploidy and clinical outcomes. Human Reproduction, 41(Supplement_1). https://doi.org/10.1093/humrep/deag083.1055

Vancouver

Teles G, Cavagnoli M, Ambrósio V, Tamm M, Micucci A, Braga D, et al. L26/P-728 Oocyte quality and competence in poor ovarian reserve: Insights from AI-based assessment, morphokinetics, ploidy and clinical outcomes. Human Reproduction. 2026;41(Supplement_1). doi:10.1093/humrep/deag083.1055

BibTeX
@article{Teles2026,
  author = {Teles, G. and Cavagnoli, M. and Ambrósio, V. and Tamm, M.A. and Micucci, A. and Braga, D. and Borges, E. and Collado, M. Del},
  title = {L26/P-728 Oocyte quality and competence in poor ovarian reserve: Insights from AI-based assessment, morphokinetics, ploidy and clinical outcomes},
  journal = {Human Reproduction},
  year = {2026},
  volume = {41},
  number = {Supplement_1},
  doi = {10.1093/humrep/deag083.1055}
}
Kostenlos starten →